$CLVS WallStreet brokerages, predict that Clovis Oncology (NASDAQ:CLVS) will post ($1.02) earnings per share for the current fiscal quarter, Zacks reports. Four analysts have provided estimates for Clovis Oncology’s earnings, with the highest EPS estimate coming in at ($0.86) and the lowest estimate coming in at ($1.18). Clovis Oncology posted earnings of ($2.27) per share in the same quarter last year, which indicates a positive year over year growth rate of 55.1%. The firm is expected to announce its next earnings report after the market closes on Thursday, August 6th. On average, analysts expect that Clovis Oncology will report full year earnings of ($4.44) per share for the current fiscal year, with EPS estimates ranging from ($4.86) to ($3.91). For the next year, analysts anticipate that the company will report earnings of ($2.56) per share, with EPS estimates ranging from ($3.50) to ($1.46). Zacks’ EPS calculations are an average. tickerreport.com/banking-fi...
  • 6
6 Likes